Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep rTMS and Varenicline for Smoking Cessation
NCT04083144Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Aug 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of varenicline in Tobacco Use Disorder (TUD), sponsored by Center for Addiction and Mental Health. Primary endpoint: Point Prevalence Abstinence at the End of 12 Weeks. Started Aug 2019; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04083144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083144.